BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/24/2019 9:22:57 AM | Browse: 600 | Download: 1132
 |
Received |
|
2019-04-11 08:56 |
|
Peer-Review Started |
|
2019-04-12 09:45 |
|
To Make the First Decision |
|
2019-08-02 03:20 |
|
Return for Revision |
|
2019-08-09 01:09 |
|
Revised |
|
2019-08-13 14:08 |
|
Second Decision |
|
2019-08-23 10:52 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2019-08-26 23:33 |
|
Articles in Press |
|
2019-08-26 23:33 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2019-08-29 02:21 |
|
Typeset the Manuscript |
|
2019-09-23 00:45 |
|
Publish the Manuscript Online |
|
2019-09-24 09:22 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Case Report |
| Article Title |
Multiple myeloma complicating Guillain-Barré syndrome after bortezomib therapy: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yu-Ling Xu, Wei-Hua Zhao, Zhong-Yuan Tang, Zhong-Qing Li, Yuan Long, Peng Cheng and Jun Luo |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
No. 81660038 |
|
| Corresponding Author |
Jun Luo, PhD, Chief Doctor, Professor, Department of Hematology, the First Affiliated Hospital of Guangxi Medical University, No. 6, Shuangyong Road, Nanning 530021, Guangxi Province, China. luojungz@medmail.com.cn |
| Key Words |
Case report; Guillain-Barré syndrome; Multiple myeloma; Bortezomib; ; |
| Core Tip |
Multiple myeloma (MM) is a malignant clonal disease, which shortens the survival time. Bortezomib, a first-line drug for the treatment of MM has prolonged patient survival. Therefore, the adverse reactions have become a hot topic. We can have a better understanding of its complications and treatment through this case. |
| Publish Date |
2019-09-24 09:22 |
| Citation |
Xu YL, Zhao WH, Tang ZY, Li ZQ, Long Y, Cheng P, Luo J. Multiple myeloma complicating Guillain-Barré syndrome after bortezomib therapy: A case report. World J Clin Cases 2019; In press |
| URL |
https://www.wjgnet.com/2307-8960/full/v7/i18/2905.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v7.i18.2905 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
